Gossamer Bio Stock Fundamentals
| GOSS Stock | USD 0.70 0.04 6.06% |
Gossamer Bio fundamentals help investors to digest information that contributes to Gossamer Bio's financial success or failures. It also enables traders to predict the movement of Gossamer Stock. The fundamental analysis module provides a way to measure Gossamer Bio's intrinsic value by examining its available economic and financial indicators, including the cash flow records, the balance sheet account changes, the income statement patterns, and various microeconomic indicators and financial ratios related to Gossamer Bio stock.
Gossamer |
Gossamer Bio Company Profit Margin Analysis
Gossamer Bio's Profit Margin measures overall efficiency of a company and shows its ability to withstand competition as well as defend against adverse conditions such as rising costs, falling prices, decline in sales or management distress. Profit margin tells investors how well the company executes on its overall pricing strategies as well as how effective the company in controlling its costs.
Current Gossamer Bio Profit Margin | (0.68) % |
Most of Gossamer Bio's fundamental indicators, such as Profit Margin, are part of a valuation analysis module that helps investors searching for stocks that are currently trading at higher or lower prices than their real value. If the real value is higher than the market price, Gossamer Bio is considered to be undervalued, and we provide a buy recommendation. Otherwise, we render a sell signal.
In a nutshell, Profit Margin indicator shows the amount of money the company makes from total sales or revenue. It can provide a good insight into companies in the same sector, as well as help to identify trends of a company from year to year.
| Competition |
Based on the latest financial disclosure, Gossamer Bio has a Profit Margin of -0.6803%. This is 93.93% lower than that of the Biotechnology sector and 97.05% lower than that of the Health Care industry. The profit margin for all United States stocks is 46.43% lower than that of the firm.
Gossamer Bio Fundamental Drivers Relationships
Comparative valuation techniques use various fundamental indicators to help in determining Gossamer Bio's current stock value. Our valuation model uses many indicators to compare Gossamer Bio value to that of its competitors to determine the firm's financial worth. You can analyze the relationship between different fundamental ratios across Gossamer Bio competition to find correlations between indicators driving Gossamer Bio's intrinsic value. More Info.Gossamer Bio is rated below average in return on equity category among its peers. It is one of the top stocks in return on asset category among its peers . Comparative valuation analysis is a catch-all technique that is used if you cannot value Gossamer Bio by discounting back its dividends or cash flows. It compares the stock's price multiples to nearest competition to determine if the stock is relatively undervalued or overvalued.Gossamer Profit Margin Peer Comparison
Stock peer comparison is one of the most widely used and accepted methods of equity analyses. It analyses Gossamer Bio's direct or indirect competition against its Profit Margin to detect undervalued stocks with similar characteristics or determine the stocks which would be a good addition to a portfolio. Peer analysis of Gossamer Bio could also be used in its relative valuation, which is a method of valuing Gossamer Bio by comparing valuation metrics of similar companies.Gossamer Bio is currently under evaluation in profit margin category among its peers.
Gossamer Fundamentals
| Return On Equity | -0.9 | ||||
| Return On Asset | -0.11 | ||||
| Profit Margin | (0.68) % | ||||
| Operating Margin | (3.58) % | ||||
| Current Valuation | 34.22 M | ||||
| Shares Outstanding | 226.6 M | ||||
| Shares Owned By Insiders | 3.32 % | ||||
| Shares Owned By Institutions | 77.47 % | ||||
| Number Of Shares Shorted | 6.3 M | ||||
| Price To Earning | (4.61) X | ||||
| Price To Book | 2.91 X | ||||
| Price To Sales | 1.50 X | ||||
| EBITDA | (172.15 M) | ||||
| Net Income | (179.82 M) | ||||
| Cash And Equivalents | 304.38 M | ||||
| Cash Per Share | 3.29 X | ||||
| Total Debt | 212.46 M | ||||
| Debt To Equity | 3.86 % | ||||
| Current Ratio | 5.93 X | ||||
| Book Value Per Share | 0.24 X | ||||
| Cash Flow From Operations | (159.16 M) | ||||
| Short Ratio | 8.17 X | ||||
| Earnings Per Share | (0.25) X | ||||
| Price To Earnings To Growth | (0.63) X | ||||
| Target Price | 6.72 | ||||
| Number Of Employees | 135 | ||||
| Beta | 1.96 | ||||
| Market Capitalization | 157.63 M | ||||
| Total Asset | 311.92 M | ||||
| Retained Earnings | (1.21 B) | ||||
| Working Capital | 254.92 M | ||||
| Current Asset | 441.63 M | ||||
| Current Liabilities | 39.84 M | ||||
| Net Asset | 311.92 M |
About Gossamer Bio Fundamental Analysis
The Macroaxis Fundamental Analysis modules help investors analyze Gossamer Bio's financials across various querterly and yearly statements, indicators and fundamental ratios. We help investors to determine the real value of Gossamer Bio using virtually all public information available. We use both quantitative as well as qualitative analysis to arrive at the intrinsic value of Gossamer Bio based on its fundamental data. In general, a quantitative approach, as applied to this company, focuses on analyzing financial statements comparatively, whereas a qaualitative method uses data that is important to a company's growth but cannot be measured and presented in a numerical way.
Please read more on our fundamental analysis page.Gossamer Bio, Inc., a clinical-stage biopharmaceutical company, focuses on discovering, acquiring, developing, and commercializing therapeutics in the disease areas of immunology, inflammation, and oncology in the United States. Gossamer Bio, Inc. was incorporated in 2015 and is headquartered in San Diego, California. Gossamer Bio operates under Biotechnology classification in the United States and is traded on NASDAQ Exchange. It employs 185 people.
Thematic Opportunities
Explore Investment Opportunities
Additional Tools for Gossamer Stock Analysis
When running Gossamer Bio's price analysis, check to measure Gossamer Bio's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Gossamer Bio is operating at the current time. Most of Gossamer Bio's value examination focuses on studying past and present price action to predict the probability of Gossamer Bio's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Gossamer Bio's price. Additionally, you may evaluate how the addition of Gossamer Bio to your portfolios can decrease your overall portfolio volatility.